---
title: "Liquidia, An IBD 50 Stock, Tops Sales Views Amid United Therapeutics Rivalry"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295674999.md"
description: "Liquidia exceeded Wall Street's expectations for the second quarter with strong sales of its lung disease treatment, Yutrepia, experiencing double-digit growth. The company's performance as an IBD 50 stock was highlighted, showcasing its ability to surpass sales projections despite competition from United Therapeutics. This success underscores Liquidia's promising position in the market."
datetime: "2026-08-12T13:33:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295674999.md)
  - [en](https://longbridge.com/en/news/295674999.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295674999.md)
generator: "portal-rs"
---

# Liquidia, An IBD 50 Stock, Tops Sales Views Amid United Therapeutics Rivalry

Liquidia exceeded Wall Street's expectations for the second quarter with strong sales of its lung disease treatment, Yutrepia, experiencing double-digit growth. The company's performance as an IBD 50 stock was highlighted, showcasing its ability to surpass sales projections despite competition from United Therapeutics. This success underscores Liquidia's promising position in the market.

### Related Stocks

- [LQDA.US](https://longbridge.com/en/quote/LQDA.US.md)
- [UTHR.US](https://longbridge.com/en/quote/UTHR.US.md)

## Related News & Research

- [United Therapeutics seeks FDA priority review for Tyvaso label expansion in IPF](https://longbridge.com/en/news/296094667.md)
- [Liquidia (LQDA) Turns Profitable On YUTREPIA Growth, Is The Upside Already Priced In?](https://longbridge.com/en/news/296513877.md)
- [United Therapeutics CEO Chair Martine Rothblatt disposes of 9,500 shares for $4.81 million](https://longbridge.com/en/news/295974899.md)
- [Renaissance Technologies LLC Sells 198,753 Shares of Liquidia Corporation $LQDA](https://longbridge.com/en/news/296325354.md)
- [Rajeev Saggar Sells 50,000 Shares of Liquidia (NASDAQ:LQDA) Stock](https://longbridge.com/en/news/296477852.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**